 | • レポートコード：B-MOR-05094 • 出版社/出版日：Mordor Intelligence / 2018年3月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、バイオニクス（生物工学）の世界市場について調べ、バイオニクス（生物工学）の世界規模、市場動向、市場環境、製品別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・バイオニクス（生物工学）の世界市場インサイト ・バイオニクス（生物工学）の世界市場環境 ・バイオニクス（生物工学）の世界市場動向 ・バイオニクス（生物工学）の世界市場規模 ・バイオニクス（生物工学）の世界市場規模：製品別 ・バイオニクス（生物工学）の世界市場：地域別市場規模・分析 ・バイオニクス（生物工学）の北米市場規模・予測 ・バイオニクス（生物工学）のアメリカ市場規模・予測 ・バイオニクス（生物工学）のヨーロッパ市場規模・予測 ・バイオニクス（生物工学）のアジア市場規模・予測 ・バイオニクス（生物工学）の日本市場規模・予測 ・バイオニクス（生物工学）の中国市場規模・予測 ・バイオニクス（生物工学）のインド市場規模・予測 ・バイオニクス（生物工学）の韓国市場規模・予測 ・関連企業情報・競争状況 |
Bionics are man-made devices that can be implanted or integrated into humans, to either replace a natural organ or provide support to restore specific function, or a group of related functions, helping the patient to return to his normal life. The global bionics market is expected to register a CAGR of 9.5% during the forecast period (2018 – 2023).
Scarcity of Donor Organs
The lack of availability of potential organs to transplant has been a major issue. The demand for organ donors is ever increasing and is very high, when compared to the actual supply. It has been estimated that of all the patients who need organ transplantation, only 10% are able to undergo the process. This has been a major boost for bionics market, as the patients cannot afford to wait in the queue, since the stakes are very high. Bionics are able to cater to the needs of those in need of organ transplantations and replacements. Bionics can replicate the function of damaged organs. The replication is almost the same. This level of scarcity of organs has turned into a boon for artificial organs and bionics industry.
Increased incidence of disabilities and organ failures, technological advancements and high incidence of road accidents leading to amputations, are some of the other factors contributing to the growth of the market.
Expensive Procedures
The cost of the procedure is a major constraint for the bionics market. The high cost of these organs is due to the production policies to address the patients, taxpayers, and medical technology corporations. For instance, organ transplant has many issues in the current market scenario, such as the policies for procurement, transplant tourism, organ trafficking, and others.
Each year, there are about 32,500 people at the age of 55-70 years in the final stages of their heart diseases, and are in need of an artificial heart. However, the protocol requiring written consent of the patient, limits the number to 12,000. The estimates of the cost of the organ, surgical procedure, device, and continuing surveillance of the patients, are in the range of USD 100,000-USD 300,000.
Additionally, fear of device malfunction and its consequences and limited specialists to carry out the procedure, are also restraining the growth of the bionics market.
North America to Lead the Market
The global bionics market is segmented by product and geography. By geography, it is segmented into North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
North America the largest share in the bionic implant space. Also, the market is emerging due to the rise in the population, coupled with awareness among the players and the patients. Growing income levels, increasing healthcare expenditure, and less competition than mature countries, are the factors that are responsible for an increase in the interest of market players in emerging markets.
Key Developments in the Market
• February 2018: Abiomed received approval for an expanded FDA indication for the Impella 2.5® and Impella CP® heart pumps, during elective and urgent high-risk percutaneous coronary intervention (PCI) procedures
Major players: ABIOMED,ASAHI KASEI MEDICAL CO. LTD, BAXTER INTERNATIONAL INC., COCHLEAR LIMITED, CYBERONICS INC., EDWARD LIFESCIENCES, EKSO BIONICS, ROCHE HOLDING AG, AND MEDTRONIC, amongst others
Reasons to Purchase The Report
• Market analysis for the global bionics market, with region-specific assessments and competition analysis, on a global and regional scale
• Analyze various perspectives of the industry, with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness the fastest growth, during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 month analyst support, along with the market estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (Droc)
6.1 Market Drivers
6.1.1 Scarcity of Donor Organs
6.1.2 Increased Incidence of Disabilities and Organ Failures
6.1.3 Technological Advancements
6.1.4 High Incidence of Road Accidents Leading to Amputations
6.2 Market Restraints
6.2.1 Expensive Procedures
6.2.2 Fear Of Device Malfunction And Its Consequences
6.2.3 Limited Specialists To Carry Out The Procedure
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product
7.1.1 Bionics
7.1.1.1 Vision Bionics
7.1.1.2 Ear Bionics
7.1.1.2.1 Cochlear Implant
7.1.1.2.2 Bone Anchored Hearing Aid (BAHA)
7.1.1.3 Orthopedic Bionic
7.1.1.3.1 Bionic Hand
7.1.1.3.2 Bionic Leg
7.1.1.4 Cardiac Bionics
7.1.1.4.1 Heart Valves
7.1.1.4.2 Ventricular Assisted Device
7.1.1.4.3 Pacemaker
7.1.1.4.4 Others
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 France
7.2.2.2 UK
7.2.2.3 Germany
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 India
7.2.3.2 China
7.2.3.3 Japan
7.2.3.4 Australia
7.2.3.5 South Korea
7.2.3.6 Rest of APAC
7.2.4 Middle East And Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Product Launches
9. Key Players
9.1 ABIOMED
9.2 Asahi Kasei Medical Co. Ltd
9.3 Baxter International Inc.
9.4 Cochlear Limited
9.5 Cyberonics Inc.
9.6 Edward Lifesciences
9.7 Ekso Bionics
9.8 Roche Holding AG
9.9 Medtronic
9.10 Others
10. Future of the Market